Otto Bock HealthCare
Ottobock develops and sells prosthetic and orthotic components, neuro-orthotics, exoskeletons and mobility aids. It sells to orthopedic clinics and healthcare providers (B2B) and to patients through its own patient-care network (B2C). That network has over 430 clinics, and the company operates in 45 countries. Group revenue was about €1.68 billion in 2025, and H1 2026 core revenue rose 7.7% to €818.5 million. The company has about 9,300 FTEs, is listed on the stock exchange (OBCK) and is majority-owned by Näder Holding. It was founded in Berlin in 1919 and is run from Duderstadt.
Funding
Every round, secondary, debt facility or acquisition involving Otto Bock HealthCare that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in